Schedule Recognition Conference Information A26
Bioethics Funding at the National Institutes of Health (NIH)
Faculty: Liza Dawson, Samual Garner, Valery M. Gordon, Ann Hardy, Joseph Millum, Holly A. Taylor Presenters of this session will include NIH program officers responsible for bioethics grants, and time will be allocated for questions and answers about the grant funding process. In this session, faculty and attendees will: • Review the NIH’s record of funding for bioethics research. • Explore currently available NIH bioethics funding opportunities. • Review the application process for NIH grants. • Discuss what types of empirical or conceptual bioethics projects are most informative for the human research oversight community, and what bioethics research topics and questions are of most interest and importance in the field.
Exhibit Hall D
Common Ground Networking Lunch
Time to connect… over lunch! Meet peers for conversation and networking. The tables will be divided by institution type: University/College (Medical), University/College (Non-Medical), Hospital/Medical Center, Government Agency, Pharma/Biotech Company, and Small Research Programs. We will also have tables available for those wishing to “just lunch.”
Research Ethics Book Group Lunch: The Professional Guinea Pig: Big Pharma and the Risky World of Human Subjects
Participate with your peers in a vibrant discussion of The Professional Guinea Pig: Big Pharma and the Risky World of Human Subjects by Roberto Abadie. Copies of Dr. Abadie’s book are available at the onsite Bookstore.
Exhibit Hall C
Meet and Greet the Conference Supporters, Exhibitors, and Poster Presenters
Network with this year’s conference Supporters, Exhibitors, and Poster Presenters in The Conference Connection during or after lunch.
p rim&r’ s 20 1 3 2 adv anci ng e ti thhi cal re se a rc h c on f e r e n c e
Panel I: When Research Offends: Ethics, IRB Review, and the Risk of Stigma
Moderator: David H. Strauss Panelists: Walter Bockting, Carl Hart, Susan Brown Trinidad Are there scientific questions, which by their very nature risk offending subject populations and therefore should not be asked? What are the obligations of the IRB around protecting groups of subjects from stigma or burden resulting from research findings and their application? This panel will examine research and the role of research oversight in relation to stigma and stereotype with a focus on race, ethnicity, and sexuality.
Innovations A: Innovations in Research on Controversial Topics
Moderator:Steven Joffe Panelists: Hila Berger, Lindsay McNair, Holly A. Taylor, Dorothy E. Vawter The Belmont Report outlines three basic ethical principles as particularly relevant to research with human subjects: respect for persons, beneficence, and justice. In the most straightforward settings, balancing these principles requires careful consideration. When research is conducted on controversial topics or in sensitive settings about which there may be limited literature, deliberations about how to balance ethical principles can be particularly complex. This panel will highlight the ethical and practical challenges of conducting controversial research using four examples: protocols using sex offenders as subjects, surgical innovation and research, placebo and lesion controlled surgical trials, and research conducted in disaster settings.
Innovations B: Innovations in Genomics and Biobanking
Moderator: Paul S. Appelbaum Panelists: Francesca Gould, Erin Luetkemeier, Jennifer Shaw Research involving the use of biospecimens is becoming more prevalent, yet many questions about best practices remain. For instance, what are the implications of the possibility of genomic findings when the biospecimens are those of children? How is pharmacogenomics research perceived in communities where past research has cultivated and perpetuated
Digital version fo the Conference Guide for the 2013 Advancing Ethical Research Conference